GALNT6 and neoplasm: By day 60 post inoculation, while all of the PC9-shNC tumor-bearing mice died, 50% of the mice bearing PC9-shG6-1 tumors survived indicating that GALNT6 silencing prolonged the survival of tumor-bearing mice (P < 0.01, Fig. 4c).